The study by Yi et al. investigates the effectiveness of intratumor injection of interferon-elastin-like polypeptide (IFN-ELP(V)) combined with resveratrol in treating glioblastoma, particularly in patients who cannot undergo surgical resection [246]. The gene discussed is NR5A1; the disease is glioblastoma.